Clinical trials: Sexual; Sexual Desire
Sexual Interest/Arousal Disorder
Cognitive-Behavioural Couple Therapy for Sexual Interest/Arousal Disorder
Sexual health is a fundamental aspect of quality of life; a satisfying sexual relationship is linked to better physical, psychological, and relationship health and well-being.
- Trial name
- CBCT for SIAD (NCT06777277)
- Testing
- Cognitive-behavioral therapy
- Where
- 3 sites in Canada
- Volunteers
- 170 people
- Sponsor
- Dalhousie University
Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
This study is open to women who have early-stage breast cancer and are on aromatase inhibitor (AI) therapy, and who have hypoactive sexual desire disorder (HSDD).
- Conditions
- Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder, Hormone Receptor Positive Breast Carcinoma, Breast Cancer
- Trial name
- NCT07596212
- Testing
- Aromatase Inhibitors, Bupropion, GnRH agonist
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Illinois Chicago
Sexual Dysfunction, Sexual Abstinence
Using of Testes' Shocker in Improving Sexual Activity
Using of testes' shocker in treating the sexual dysfunction.
- Conditions
- Sexual Dysfunction, Sexual Abstinence, Sexual Desire Disorder, Erectile Dysfunction
- Trial name
- NCT04662398
- Testing
- JT Device
- Where
- Iraq
- Volunteers
- 77 people
- Sponsor
- University of Baghdad
Menopause, Metabolic Syndrome
Low Sexual Desire and Metabolic Syndrome
Objective: To evaluate the prevalence of hypoactive sexual desire disorder (HSDD) in postmenopausal women diagnosed with metabolic syndrome (MS) and to compare it to that of a control group without MS.
- Conditions
- Menopause, Metabolic Syndrome, Hypoactive Sexual Desire Disorder, Obesity
- Trial name
- NCT02430987
- Testing
- Female sexual function index questionnaire, Evaluation of presence of metabolic syndrome, Evaluation of the body mass index
- Where
- Brazil
- Volunteers
- 291 people, healthy volunteers welcome
- Sponsor
- Faculdade de Ciências Médicas da Santa Casa de São Paulo
Female Sexual Dysfunction, Polycystic Ovary Syndrome
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
SUMMARY: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive age women with a prevalence as high as 15%.
- Trial name
- Vit-D/PCOS (NCT02865187)
- Testing
- Vitamin D, Hormonal contraception
- Where
- 2 sites in United States
- Volunteers
- 47 people
- Sponsor
- Wright State University
Transsexualism
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group
Participants fill out a questionnaire on libido and their possible partner relationship. A blood sample is taken for sex steroid analysis.
- Trial name
- NCT00135148
- Testing
- Filling out a questionnaire on libido and possible partner relationship, Sex steroid analysis
- Where
- Belgium
- Volunteers
- 150 people
- Sponsor
- University Hospital, Ghent
Sexual Dysfunction, Sexual Dysfunctions, Psychological
Mindfulness as Treatment of Sexological Problems
The primary aim of this study is to test Mindfulness in Sex Therapy and Intimate Relationships (MSIR) as an add-on treatment to sex therapy in a clinical sample of patients referred with sexual problems, controlling for time…
- Conditions
- Sexual Dysfunction, Sexual Dysfunctions, Psychological, Sexual Dysfunctions, Physiological
- Trial name
- NCT03775239
- Testing
- Mindfulness in Sex Therapy and Intimate Relationships (MSIR), Treatment-as-usual
- Where
- Denmark
- Volunteers
- 34 people
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Ovariectomy, Hysterectomy
Surveillance Study of Women Taking Intrinsa®
The primary objective of the study is to assess the risks of testosterone transdermal patch use in a representative study population. The primary clinical outcome of interest is breast cancer.
- Conditions
- Ovariectomy, Hysterectomy, Hypoactive Sexual Desire Disorder
- Trial name
- EMPOWER (NCT00551785)
- Where
- Germany
- Volunteers
- 328 people
- Sponsor
- Center for Epidemiology and Health Research, Germany
Sexual Dysfunctions, Psychological
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
This trial is designed to assess the safety and efficacy of flibanserin in the treatment of premenopausal women with Hypoactive Sexual Desire Disorder (HSDD) that meets standard diagnostic criteria.
- Trial name
- NCT00360555
- Testing
- flibanserin, flibanserin 50mg, flibanserin 100mg
- Where
- 77 sites in United States, Canada
- Volunteers
- 1,584 people
- Sponsor
- Sprout Pharmaceuticals, Inc
Sex Behavior
Safety Study of Transdermal Testosterone for Low Libido in Pre and Postmenopausal Women
Female sexual dysfunction (FSD) is an established side effect of Selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitors (SNRIs), causing symptoms such as loss of libido, arousal…
- Trial name
- TESTOSTERONE (NCT02215434)
- Testing
- Testosterone, Transdermal, Behavior
- Where
- Brazil
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University Potiguar
Female Sexual Arousal Disorder
Clinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Function in Postmenopausal Women.
This clinical Trial will assess the effects of a dietary supplement based on Tribulus terrestris on the libido and sexual function in postmenopausal women, by doing a follow up of the FSFI scale and different variables during 3…
- Trial name
- NCT03820453
- Testing
- Tribulus Terrestris
- Where
- 4 sites in Spain
- Volunteers
- 110 people
- Sponsor
- Kern Pharma, S.L.
Hypoactive Sexual Desire Disorder
2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the…
- Trial name
- HSDD (NCT02338960)
- Testing
- Bremelanotide
- Where
- 91 sites in United States, Canada
- Volunteers
- 714 people
- Sponsor
- Palatin Technologies, Inc
Hypoactive Sexual Desire Disorder, Erectile Dysfunction
A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality
The current study combines a molecular genetic perspective, self report and brain imaging to the study of human sexuality in control subjects and individuals from a sexual disorder clinic.
- Trial name
- NCT00569413
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Hadassah Medical Organization
Hypoactive Sexual Desire Disorder
Testosterone in Female Hypoactive Sexual Desire Disorder
The success of sildenafil in the treatment of erectile dysfunction has led to efforts to find similar treatments for prevalent disorders of female sexual dysfunction.
- Trial name
- NCT00140153
- Testing
- testosterone gel (Androgel)
- Where
- Israel
- Volunteers
- 20 people
- Sponsor
- Beersheva Mental Health Center
Menopause, Sexual Desire Disorder
Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women
The objective of this study is the role of vaginal progesterone gel in the treatment of menopausal hypoactive sexual desire disorder.
- Conditions
- Menopause, Sexual Desire Disorder, Hypoactive Sexual Desire Disorder
- Trial name
- NCT02968342
- Testing
- Vaginal progesterone 8%
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Bezmialem Vakif University
Child Sexual Abuse, Pedophilia
Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children
The overall aim of the study is to evaluate the effectiveness of Mi Bridge to motivate high risk participants to admit to treatment.
- Trial name
- Mi Bridge (NCT06133595)
- Testing
- Behavioral: MiBridge
- Where
- 6 sites in Czechia, Finland and 4 more
- Volunteers
- 60 people
- Sponsor
- Karolinska Institutet
Hypoactive Sexual Desire Disfunction
Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder
Hypoactive Sexual Desire Disorder (HSDD) is the most prevalent female sexual dysfunction in society and is strongly linked to the quality of life of women.
- Trial name
- NCT01971099
- Testing
- tribulus terrestris
- Where
- Brazil
- Volunteers
- 44 people
- Sponsor
- Federal University of Minas Gerais
Hypoactive Sexual Desire Disorder
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogen/progestin therapy.
- Trial name
- NCT00338312
- Testing
- Testosterone Transdermal System
- Where
- United States
- Volunteers
- 610 people
- Sponsor
- Warner Chilcott
Hypoactive Sexual Desire Disorder, Vulvovaginal Disease
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
The regulation of clitoral vascularization by sex steroids is still under-investigated. We aimed to explore the effects of 6 months transdermal Testosterone (T) therapy on clitoral color Doppler ultrasound (CDU) parameters in…
- Conditions
- Hypoactive Sexual Desire Disorder, Vulvovaginal Disease, Menopause Related Conditions, Dyspareunia (Female Excluding Psychogenic)
- Trial name
- TESTOFSD (NCT04336891)
- Testing
- Testosterone gel, Estradiol ovules, Moisturizer
- Where
- Italy
- Volunteers
- 81 people
- Sponsor
- University of Florence
Female Sexual Arousal Disorder, Hypoactive Sexual Desire Disorder
Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide, administered subcutaneously on an as-needed basis under conditions of home use, for the treatment of female sexual arousal…
- Trial name
- NCT01382719
- Testing
- bremelanotide
- Where
- 68 sites in United States, Canada
- Volunteers
- 612 people
- Sponsor
- Palatin Technologies, Inc